Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Oxidative stress and pathological changes after coronary artery interventions.

Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1471-81. doi: 10.1016/j.jacc.2012.11.068. Review.

2.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
3.

Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.

Montezano AC, Touyz RM.

Basic Clin Pharmacol Toxicol. 2012 Jan;110(1):87-94. doi: 10.1111/j.1742-7843.2011.00785.x. Epub 2011 Sep 28. Review.

4.

Prevention of restenosis with antioxidants: mechanisms and implications.

Tardif JC, Grégoire J, L'Allier PL.

Am J Cardiovasc Drugs. 2002;2(5):323-34. Review.

PMID:
14727962
5.

Dexamethasone-eluting vascular stents.

Hämäläinen M, Nieminen R, Uurto I, Salenius JP, Kellomäki M, Mikkonen J, Kotsar A, Isotalo T, Teuvo Tammela LJ, Talja M, Moilanen E.

Basic Clin Pharmacol Toxicol. 2013 May;112(5):296-301. doi: 10.1111/bcpt.12056. Epub 2013 Mar 9. Review.

6.

Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Montezano AC, Touyz RM.

Can J Cardiol. 2012 May;28(3):288-95. doi: 10.1016/j.cjca.2012.01.017. Epub 2012 Mar 23. Review.

PMID:
22445098
7.
8.

Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention.

Hamasaki S, Tei C.

J Cardiol. 2011 May;57(3):231-8. doi: 10.1016/j.jjcc.2011.02.003. Epub 2011 Mar 12. Review.

9.

Nitric oxide and oxidative stress in vascular disease.

Förstermann U.

Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Epub 2010 Mar 21. Review.

PMID:
20306272
10.

The iatrogenic pathology of percutaneous interventions in coronary arteries.

Li X, De Winter RJ, Van Der Wal AC.

Minerva Med. 2012 Dec;103(6):487-502. Review.

PMID:
23229368
11.

Indications of coronary angioplasty and stenting in 2003: what is left to surgery?

Poyen V, Silvestri M, Labrunie P, Valeix B.

J Cardiovasc Surg (Torino). 2003 Jun;44(3):307-12. Review.

PMID:
12832982
12.

Reactive oxygen species in vascular wall.

Yung LM, Leung FP, Yao X, Chen ZY, Huang Y.

Cardiovasc Hematol Disord Drug Targets. 2006 Mar;6(1):1-19. Review.

PMID:
16724932
13.

Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.

Bonello L, De Labriolle A, Lemesle G, Roy P, Steinberg DH, Pichard AD, Waksman R.

Arch Cardiovasc Dis. 2009 Feb;102(2):143-51. doi: 10.1016/j.acvd.2008.11.002. Epub 2009 Feb 7. Review.

14.

The importance of the endothelium in atherothrombosis and coronary stenting.

Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R.

Nat Rev Cardiol. 2012 May 22;9(8):439-53. doi: 10.1038/nrcardio.2012.64. Review. Erratum in: Nat Rev Cardiol. 2013 Jun;10(6):300.

PMID:
22614618
15.

Drug-eluting stents vs. intracoronary brachytherapy for in-stent restenosis: a meta-analysis.

Lu YG, Chen YM, Li L, Zhao RZ, Fu CH, Yan H.

Clin Cardiol. 2011 Jun;34(6):344-51. doi: 10.1002/clc.20900. Epub 2011 Apr 27. Review.

16.
17.

Perspectives of drug-eluting stents: the next revolution.

Moses JW, Kipshidze N, Leon MB.

Am J Cardiovasc Drugs. 2002;2(3):163-72. Review.

PMID:
14727979
18.

Do statins have a role in reduction/prevention of post-PCI restenosis?

Prasad K.

Cardiovasc Ther. 2013 Feb;31(1):12-26. doi: 10.1111/j.1755-5922.2011.00302.x. Epub 2011 Oct 3. Review.

PMID:
21967674
19.

Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications.

Higashi Y, Maruhashi T, Noma K, Kihara Y.

Trends Cardiovasc Med. 2014 May;24(4):165-9. doi: 10.1016/j.tcm.2013.12.001. Epub 2013 Dec 4. Review.

PMID:
24373981
20.

From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence.

Navarese EP, Castriota F, Sangiorgi GM, Cremonesi A.

Minerva Cardioangiol. 2013 Apr;61(2):243-54. Review.

PMID:
23492607
Items per page

Supplemental Content

Write to the Help Desk